Kala Bio Inc.. (KALA) NASDAQ
$6.32 (0.08) (-1.25%)
Market Cap: $18.03M
As of 04/25/24 10:07 AM EDT. Market open.
Kala Bio Inc.. (KALA)
NASDAQ
$6.32
(0.08) (-1.25%)
Market Cap: $18.03M
As of 04/25/24 10:07 AM EDT. Market open.
Add to Portfolio
kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Mark Iwicki
Full Time Employees
111
CEO Compensation (Base)
$534,681
CEO Compensation (Total)
$3.07M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Mark Iwicki
Full Time Employees
111
CEO Compensation (Base)
$534,681
CEO Compensation (Total)
$3.07M
URL
Address
490 Arsenal Way, Suite 120, Massachusetts, Watertown, 02472.
PRICE CHART FOR KALA BIO INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.32
Previous Close
$6.40
Days Range
$6.35 - $6.48
52 week range
$5.10 - $19.35
Volume
1,692
Avg. Volume (30 days)
12,857
Market Cap
$18.03M
Dividend Yield
-
P/E
(2.09)
Shares Outstanding
2,816,454
Open
$6.32
Previous Close
$6.40
Days Range
$6.35 - $6.48
52 week range
$5.10 - $19.35
Volume
1,692
Avg. Volume (30 days)
12,857
Market Cap
$18.03M
Dividend Yield
-
P/E
(2.09)
Shares Outstanding
2,816,454
FINANCIAL STATEMENTS FOR KALA BIO INC.
LOADING...
INSIDER TRANSACTIONS FOR KALA BIO INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Trachtenberg Eric | SEE REMARKS | Jan 04, 2024 | Sale | $6.74 | 1,227 | 8,270 | 68,066 | Jan 05, 2024, 04:07 PM |
Kharabi Darius | CHIEF BUSINESS OFFICER | Jan 04, 2024 | Sale | $6.73 | 1,385 | 9,321 | 65,117 | Jan 05, 2024, 04:06 PM |
Brazzell Romulus K | SEE REMARKS | Jan 04, 2024 | Sale | $6.74 | 1,617 | 10,899 | 91,473 | Jan 05, 2024, 04:05 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jan 04, 2024 | Sale | $6.73 | 4,539 | 30,547 | 286,315 | Jan 05, 2024, 04:04 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Jan 04, 2024 | Sale | $6.74 | 1,227 | 8,270 | 66,136 | Jan 05, 2024, 04:04 PM |
Bazemore Todd | SEE REMARKS | Jan 04, 2024 | Sale | $6.74 | 1,405 | 9,470 | 89,786 | Jan 05, 2024, 04:03 PM |
Trachtenberg Eric | SEE REMARKS | Jan 04, 2023 | Sale | $28.55 | 60 | 1,713 | 11,495 | Jan 06, 2023, 08:00 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Jan 04, 2023 | Sale | $28.54 | 60 | 1,712 | 11,883 | Jan 06, 2023, 08:00 PM |
Brazzell Romulus K | SEE REMARKS | Jan 04, 2023 | Sale | $28.53 | 73 | 2,083 | 18,536 | Jan 06, 2023, 08:00 PM |
Bazemore Todd | SEE REMARKS | Jan 04, 2023 | Sale | $28.54 | 62 | 1,769 | 14,835 | Jan 06, 2023, 08:00 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jan 04, 2023 | Sale | $28.54 | 198 | 5,651 | 45,966 | Jan 06, 2023, 08:00 PM |
Trachtenberg Eric | SEE REMARKS | Oct 26, 2022 | Sale | $6.52 | 194 | 1,265 | 2,030 | Oct 28, 2022, 04:15 PM |
Bazemore Todd | SEE REMARKS | Oct 26, 2022 | Sale | $6.51 | 214 | 1,393 | 2,097 | Oct 28, 2022, 04:15 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Oct 26, 2022 | Sale | $6.51 | 194 | 1,263 | 2,418 | Oct 28, 2022, 04:15 PM |
Brazzell Romulus K | SEE REMARKS | Oct 26, 2022 | Sale | $6.51 | 261 | 1,699 | 5,809 | Oct 28, 2022, 04:15 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Oct 26, 2022 | Sale | $6.52 | 561 | 3,658 | 4,464 | Oct 28, 2022, 04:15 PM |
Trachtenberg Eric | SEE REMARKS | Jun 27, 2022 | Sale | $0.37 | 2,613 | 967 | 111,203 | Jun 29, 2022, 08:12 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Jun 27, 2022 | Sale | $0.37 | 2,613 | 967 | 130,595 | Jun 29, 2022, 08:12 PM |
Brazzell Romulus K | SEE REMARKS | Jun 27, 2022 | Sale | $0.37 | 3,144 | 1,163 | 285,201 | Jun 29, 2022, 08:11 PM |
Bazemore Todd | SEE REMARKS | Jun 27, 2022 | Sale | $0.37 | 3,092 | 1,144 | 115,499 | Jun 29, 2022, 08:10 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jun 27, 2022 | Sale | $0.37 | 7,975 | 2,951 | 251,183 | Jun 29, 2022, 08:09 PM |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 26, 2022 | Sale | $0.36 | 1,005,686 | 365,667 | 7,039,613 | May 26, 2022, 05:09 PM |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 25, 2022 | Sale | $0.42 | 1,434,509 | 602,494 | 8,045,299 | May 25, 2022, 05:17 PM |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 24, 2022 | Sale | $0.51 | 144,805 | 73,851 | 9,479,808 | May 25, 2022, 05:17 PM |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 23, 2022 | Sale | $0.65 | 1,250,000 | 812,500 | 9,624,613 | May 25, 2022, 05:17 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Jan 04, 2022 | Sale | $1.30 | 2,850 | 3,705 | 133,208 | Jan 05, 2022, 08:00 PM |
Brazzell Romulus K | SEE REMARKS | Jan 04, 2022 | Sale | $1.30 | 3,504 | 4,555 | 288,345 | Jan 05, 2022, 08:00 PM |
Bazemore Todd | SEE REMARKS | Jan 04, 2022 | Sale | $1.30 | 3,454 | 4,490 | 118,591 | Jan 05, 2022, 08:00 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jan 04, 2022 | Sale | $1.30 | 9,518 | 12,373 | 259,158 | Jan 05, 2022, 08:00 PM |
Trachtenberg Eric | SEE REMARKS | Jan 04, 2022 | Sale | $1.30 | 2,850 | 3,705 | 113,816 | Jan 05, 2022, 08:00 PM |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | Oct 27, 2021 | Sale | $1.82 | 21,051 | 38,313 | 204,515 | Oct 28, 2021, 08:06 PM |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | Oct 26, 2021 | Sale | $1.80 | 9,449 | 17,008 | 225,566 | Oct 28, 2021, 08:06 PM |
Trachtenberg Eric | SEE REMARKS | Oct 26, 2021 | Sale | $1.80 | 9,449 | 17,008 | 116,666 | Oct 28, 2021, 08:05 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Oct 26, 2021 | Sale | $1.80 | 9,449 | 17,008 | 136,058 | Oct 28, 2021, 08:04 PM |
Bazemore Todd | CHIEF OPERATING OFFICER | Oct 26, 2021 | Sale | $1.80 | 12,544 | 22,579 | 122,045 | Oct 28, 2021, 08:03 PM |
Brazzell Romulus K | CHIEF MEDICAL OFFICER | Oct 26, 2021 | Sale | $1.80 | 12,757 | 22,963 | 291,849 | Oct 28, 2021, 08:02 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Oct 26, 2021 | Sale | $1.80 | 27,598 | 49,676 | 268,676 | Oct 28, 2021, 08:01 PM |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | Jun 29, 2021 | Sale | $5.56 | 5,548 | 30,847 | 235,015 | Jun 30, 2021, 05:30 PM |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | Jun 28, 2021 | Sale | $5.77 | 2,452 | 14,148 | 240,563 | Jun 29, 2021, 05:26 PM |
Brazzell Romulus K | CHIEF MEDICAL OFFICER | Jun 28, 2021 | Sale | $5.77 | 3,034 | 17,506 | 300,962 | Jun 29, 2021, 05:26 PM |
Trachtenberg Eric | SEE REMARKS | Jun 28, 2021 | Sale | $5.77 | 2,452 | 14,148 | 126,115 | Jun 29, 2021, 05:26 PM |
Reumuth Mary | CHIEF FINANCIAL OFFICER | Jun 28, 2021 | Sale | $5.77 | 2,452 | 14,148 | 145,507 | Jun 29, 2021, 05:26 PM |
Bazemore Todd | CHIEF OPERATING OFFICER | Jun 28, 2021 | Sale | $5.77 | 2,911 | 16,796 | 134,589 | Jun 29, 2021, 05:25 PM |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jun 28, 2021 | Sale | $5.77 | 7,586 | 43,771 | 296,274 | Jun 29, 2021, 05:25 PM |
Chen Hongming | Chief Scientific Officer | Mar 01, 2021 | Option Exercise | $2.30 | 9,500 | 21,850 | 243,015 | Mar 03, 2021, 12:00 AM |
Chen Hongming | Chief Scientific Officer | Feb 25, 2021 | Option Exercise | $2.30 | 47,000 | 108,100 | 233,515 | Feb 26, 2021, 05:35 PM |
Bazemore Todd | Chief Operating Officer | Oct 22, 2020 | Buy | $7.60 | 40 | 304 | 42 | Oct 28, 2020, 08:36 PM |
Bazemore Todd | Chief Operating Officer | Jun 05, 2020 | Buy | $13.39 | 2 | 27 | 2 | Oct 28, 2020, 08:36 PM |
Rosen Howard B | Director | Aug 19, 2019 | Option Exercise | $0.60 | 4,824 | 2,872 | 4,824 | Jun 29, 2020, 09:54 PM |
Trachtenberg Eric | See Remarks | Jun 19, 2020 | Option Exercise | $5.19 | 28,901 | 149,996 | 28,901 | Jun 22, 2020, 04:06 PM |
Reumuth Mary | Chief Financial Officer | Jun 09, 2020 | Option Exercise | $2.64 | 43,477 | 114,771 | 48,293 | Jun 11, 2020, 04:58 PM |
Brazzell Romulus K | Chief Medical Officer | Apr 09, 2020 | Option Exercise | $2.99 | 67,771 | 202,377 | 176,496 | Apr 13, 2020, 08:38 AM |
Chen Hongming | Chief Scientific Officer | Mar 30, 2020 | Option Exercise | $2.30 | 31,000 | 71,300 | 86,849 | Apr 01, 2020, 04:43 PM |
Bazemore Todd | Chief Operating Officer | Mar 16, 2020 | Buy | $5.75 | 10,000 | 57,500 | 10,000 | Mar 17, 2020, 05:46 PM |
Grunberg Gregory | Director | Mar 13, 2020 | Buy | $7.89 | 2,534,854 | 19,999,998 | 2,534,854 | Mar 16, 2020, 07:59 AM |
Shah Rajeev M. | Director | Mar 13, 2020 | Buy | $7.89 | 6,337,135 | 49,999,994 | 10,874,613 | Mar 13, 2020, 06:47 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Mar 13, 2020 | Buy | $7.89 | 6,337,135 | 49,999,994 | 10,874,613 | Mar 13, 2020, 06:45 PM |
Rosen Howard B | Director | May 30, 2019 | Buy | $5.42 | 5,000 | 27,100 | 8,240 | Jun 03, 2019, 10:41 AM |
Grunberg Gregory | Director | Oct 05, 2018 | Buy | $8.25 | 606,060 | 4,999,995 | 2,877,006 | Oct 09, 2018, 04:46 PM |
Shah Rajeev M. | Director | Oct 03, 2018 | Buy | $8.25 | 2,424,242 | 19,999,997 | 4,537,478 | Oct 05, 2018, 04:34 PM |
RA CAPITAL MANAGEMENT, LLC | Director | Oct 03, 2018 | Buy | $8.25 | 2,424,242 | 19,999,997 | 4,537,478 | Oct 05, 2018, 04:33 PM |
Chen Hongming | Chief Scientific Officer | Feb 28, 2018 | Option Exercise | $2.26 | 9,769 | 22,123 | 55,849 | Mar 02, 2018, 05:19 PM |
ORBIMED ADVISORS LLC | 10% Owner | Feb 08, 2018 | Buy | $12.93 | 25,000 | 323,250 | 3,447,840 | Feb 12, 2018, 04:35 PM |
ORBIMED ADVISORS LLC | 10% Owner | Feb 02, 2018 | Buy | $14.73 | 37,840 | 557,383 | 3,422,840 | Feb 06, 2018, 05:05 PM |
ORBIMED ADVISORS LLC | 10% Owner | Feb 01, 2018 | Buy | $14.99 | 22,840 | 342,372 | 3,385,000 | Feb 02, 2018, 05:45 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 31, 2018 | Buy | $15.00 | 339,400 | 5,091,000 | 3,362,160 | Feb 02, 2018, 05:45 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 29, 2018 | Buy | $14.99 | 50,000 | 749,500 | 3,022,760 | Jan 30, 2018, 03:34 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 26, 2018 | Buy | $14.93 | 22,760 | 339,807 | 2,972,760 | Jan 30, 2018, 03:34 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 19, 2018 | Buy | $14.95 | 74,931 | 1,120,218 | 2,806,000 | Jan 24, 2018, 08:59 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 12, 2018 | Buy | $14.50 | 38,354 | 556,133 | 2,731,069 | Jan 24, 2018, 08:59 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 24, 2018 | Buy | $14.91 | 64,637 | 963,738 | 2,950,000 | Jan 24, 2018, 08:59 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 23, 2018 | Buy | $14.99 | 4,363 | 65,401 | 2,885,363 | Jan 24, 2018, 08:59 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 22, 2018 | Buy | $14.98 | 75,000 | 1,123,500 | 2,881,000 | Jan 24, 2018, 08:59 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 12, 2018 | Buy | $15.40 | 28,446 | 438,068 | 2,692,715 | Jan 12, 2018, 05:29 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 11, 2018 | Buy | $13.65 | 41,700 | 569,205 | 2,664,269 | Jan 12, 2018, 05:29 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 10, 2018 | Buy | $12.83 | 170,338 | 2,185,437 | 2,622,569 | Jan 12, 2018, 05:29 PM |
Brazzell Romulus K | Chief Medical Officer | Aug 11, 2017 | Option Exercise | $1.64 | 108,725 | 178,039 | 108,725 | Aug 15, 2017, 04:08 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jul 25, 2017 | Buy | $15.00 | 319,333 | 4,789,995 | 2,375,279 | Jul 27, 2017, 07:17 PM |
Longitude Capital Partners II, LLC | 10% Owner | Jul 25, 2017 | Buy | $15.00 | 215,000 | 3,225,000 | 2,270,946 | Jul 27, 2017, 05:23 PM |
RA CAPITAL MANAGEMENT, LLC | Director | Jul 25, 2017 | Buy | $15.00 | 533,333 | 7,999,995 | 2,113,236 | Jul 26, 2017, 04:44 PM |
Grunberg Gregory | Director | Jul 25, 2017 | Buy | $15.00 | 215,000 | 3,225,000 | 2,270,946 | Jul 26, 2017, 04:31 PM |
Shah Rajeev M. | Director | Jul 25, 2017 | Buy | $15.00 | 533,333 | 7,999,995 | 2,113,236 | Jul 26, 2017, 04:31 PM |
CDK ASSOCIATES, L.L.C. | 10% Owner | Jul 20, 2017 | Buy | $15.00 | 215,000 | 3,225,000 | 763,755 | Jul 21, 2017, 05:54 PM |
CDK ASSOCIATES, L.L.C. | 10% Owner | Jul 20, 2017 | Buy | $15.00 | 215,000 | 3,225,000 | 763,755 | Jul 21, 2017, 03:58 PM |
CDK ASSOCIATES, L.L.C. | 10% Owner | Jul 20, 2017 | Buy | $15.00 | 215,000 | 3,225,000 | 215,000 | Jul 20, 2017, 06:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Trachtenberg Eric | SEE REMARKS | 01/04/2024 | 8,270 |
Kharabi Darius | CHIEF BUSINESS OFFICER | 01/04/2024 | 9,321 |
Brazzell Romulus K | SEE REMARKS | 01/04/2024 | 10,899 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 01/04/2024 | 30,547 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 01/04/2024 | 8,270 |
Bazemore Todd | SEE REMARKS | 01/04/2024 | 9,470 |
Trachtenberg Eric | SEE REMARKS | 01/04/2023 | 1,713 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 01/04/2023 | 1,712 |
Brazzell Romulus K | SEE REMARKS | 01/04/2023 | 2,083 |
Bazemore Todd | SEE REMARKS | 01/04/2023 | 1,769 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 01/04/2023 | 5,651 |
Trachtenberg Eric | SEE REMARKS | 10/26/2022 | 1,265 |
Bazemore Todd | SEE REMARKS | 10/26/2022 | 1,393 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 10/26/2022 | 1,263 |
Brazzell Romulus K | SEE REMARKS | 10/26/2022 | 1,699 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 10/26/2022 | 3,658 |
Trachtenberg Eric | SEE REMARKS | 06/27/2022 | 967 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 06/27/2022 | 967 |
Brazzell Romulus K | SEE REMARKS | 06/27/2022 | 1,163 |
Bazemore Todd | SEE REMARKS | 06/27/2022 | 1,144 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 06/27/2022 | 2,951 |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 05/26/2022 | 365,667 |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 05/25/2022 | 602,494 |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 05/24/2022 | 73,851 |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 05/23/2022 | 812,500 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 01/04/2022 | 3,705 |
Brazzell Romulus K | SEE REMARKS | 01/04/2022 | 4,555 |
Bazemore Todd | SEE REMARKS | 01/04/2022 | 4,490 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 01/04/2022 | 12,373 |
Trachtenberg Eric | SEE REMARKS | 01/04/2022 | 3,705 |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | 10/27/2021 | 38,313 |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | 10/26/2021 | 17,008 |
Trachtenberg Eric | SEE REMARKS | 10/26/2021 | 17,008 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 10/26/2021 | 17,008 |
Bazemore Todd | CHIEF OPERATING OFFICER | 10/26/2021 | 22,579 |
Brazzell Romulus K | CHIEF MEDICAL OFFICER | 10/26/2021 | 22,963 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 10/26/2021 | 49,676 |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | 06/29/2021 | 30,847 |
Chen Hongming | CHIEF SCIENTIFIC OFFICER | 06/28/2021 | 14,148 |
Brazzell Romulus K | CHIEF MEDICAL OFFICER | 06/28/2021 | 17,506 |
Trachtenberg Eric | SEE REMARKS | 06/28/2021 | 14,148 |
Reumuth Mary | CHIEF FINANCIAL OFFICER | 06/28/2021 | 14,148 |
Bazemore Todd | CHIEF OPERATING OFFICER | 06/28/2021 | 16,796 |
Iwicki Mark T | CHIEF EXECUTIVE OFFICER | 06/28/2021 | 43,771 |
Chen Hongming | Chief Scientific Officer | 03/01/2021 | 21,850 |
Chen Hongming | Chief Scientific Officer | 02/25/2021 | 108,100 |
Bazemore Todd | Chief Operating Officer | 10/22/2020 | 304 |
Bazemore Todd | Chief Operating Officer | 06/05/2020 | 27 |
Rosen Howard B | Director | 08/19/2019 | 2,872 |
Trachtenberg Eric | See Remarks | 06/19/2020 | 149,996 |
Reumuth Mary | Chief Financial Officer | 06/09/2020 | 114,771 |
Brazzell Romulus K | Chief Medical Officer | 04/09/2020 | 202,377 |
Chen Hongming | Chief Scientific Officer | 03/30/2020 | 71,300 |
Bazemore Todd | Chief Operating Officer | 03/16/2020 | 57,500 |
Grunberg Gregory | Director | 03/13/2020 | 19,999,998 |
Shah Rajeev M. | Director | 03/13/2020 | 49,999,994 |
RA CAPITAL MANAGEMENT, L.P. | Director | 03/13/2020 | 49,999,994 |
Rosen Howard B | Director | 05/30/2019 | 27,100 |
Grunberg Gregory | Director | 10/05/2018 | 4,999,995 |
Shah Rajeev M. | Director | 10/03/2018 | 19,999,997 |
RA CAPITAL MANAGEMENT, LLC | Director | 10/03/2018 | 19,999,997 |
Chen Hongming | Chief Scientific Officer | 02/28/2018 | 22,123 |
ORBIMED ADVISORS LLC | 10% Owner | 02/08/2018 | 323,250 |
ORBIMED ADVISORS LLC | 10% Owner | 02/02/2018 | 557,383 |
ORBIMED ADVISORS LLC | 10% Owner | 02/01/2018 | 342,372 |
ORBIMED ADVISORS LLC | 10% Owner | 01/31/2018 | 5,091,000 |
ORBIMED ADVISORS LLC | 10% Owner | 01/29/2018 | 749,500 |
ORBIMED ADVISORS LLC | 10% Owner | 01/26/2018 | 339,807 |
ORBIMED ADVISORS LLC | 10% Owner | 01/19/2018 | 1,120,218 |
ORBIMED ADVISORS LLC | 10% Owner | 01/12/2018 | 556,133 |
ORBIMED ADVISORS LLC | 10% Owner | 01/24/2018 | 963,738 |
ORBIMED ADVISORS LLC | 10% Owner | 01/23/2018 | 65,401 |
ORBIMED ADVISORS LLC | 10% Owner | 01/22/2018 | 1,123,500 |
ORBIMED ADVISORS LLC | 10% Owner | 01/12/2018 | 438,068 |
ORBIMED ADVISORS LLC | 10% Owner | 01/11/2018 | 569,205 |
ORBIMED ADVISORS LLC | 10% Owner | 01/10/2018 | 2,185,437 |
Brazzell Romulus K | Chief Medical Officer | 08/11/2017 | 178,039 |
ORBIMED ADVISORS LLC | 10% Owner | 07/25/2017 | 4,789,995 |
Longitude Capital Partners II, LLC | 10% Owner | 07/25/2017 | 3,225,000 |
RA CAPITAL MANAGEMENT, LLC | Director | 07/25/2017 | 7,999,995 |
Grunberg Gregory | Director | 07/25/2017 | 3,225,000 |
Shah Rajeev M. | Director | 07/25/2017 | 7,999,995 |
CDK ASSOCIATES, L.L.C. | 10% Owner | 07/20/2017 | 3,225,000 |
CDK ASSOCIATES, L.L.C. | 10% Owner | 07/20/2017 | 3,225,000 |
CDK ASSOCIATES, L.L.C. | 10% Owner | 07/20/2017 | 3,225,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN KALA BIO INC.
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 266,613 | 0.02% | No change | Other |
BLACKROCK INC. | 27,321 | 0% | 4.68% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 18,465 | 0.00001% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 14,100 | 0.00015% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR KALA BIO INC.
STOCK BUYBACKS FOR KALA BIO INC.
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
6.48%
1Q
06/30/2023
13.73%
2Q
03/31/2023
31.24%
3Q
09/30/2022
79.79%
5Q
06/30/2022
82.76%
6Q
03/31/2022
82.85%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR KALA BIO INC.
LOADING...